Sumatriptan succinate and Colcrys drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Colcrys (colchicine). Common drug interactions include drug ineffective among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Colcrys. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Colcrys?

Colcrys has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 4,546 Colcrys users. Check the latest studies of Colcrys.



On Jul, 07, 2026

13 people who take Sumatriptan succinate and Colcrys together, and have interactions are studied.

Sumatriptan succinate and Colcrys drug interactions.

What are the common drug interactions of Sumatriptan Succinate and Colcrys, by gender? *:

female:

  1. Drug ineffective
  2. Cardiac failure congestive
  3. Oedema peripheral (superficial swelling)
  4. Ear infection
  5. Incontinence (lack of moderation or self-control)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Cardiomegaly (increased size of heart than normal)
  8. Cor pulmonale (enlargement of the right ventricle of the heart)
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Endometrial cancer

male:

  1. Asthma
  2. Blood bicarbonate decreased
  3. Pco2 decreased
  4. Po2 increased
  5. Red cell distribution width increased
  6. Chills (felling of cold)
  7. Facial pain
  8. Headache (pain in head)
  9. Local swelling (swelling at the site of some application of substance or injury)
  10. Pulmonary congestion (congestion in the lungs)

What are the common drug interactions of Sumatriptan Succinate and Colcrys, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood ph increased
  2. Dyspnoea (difficult or laboured respiration)
  3. Haemoglobin decreased
  4. Mean platelet volume increased (more than normal average size of platelet cells in blood)
  5. Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
  6. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  7. Monocyte count increased
  8. Oxygen saturation increased
  9. Pco2 decreased
  10. Po2 increased

50-59:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Post-traumatic stress disorder

60+:

  1. Drug ineffective
  2. Cardiac failure congestive
  3. Oedema peripheral (superficial swelling)
  4. Incontinence (lack of moderation or self-control)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 38.46%
  2. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 30.77%
  3. Rashes (redness): 4 people, 30.77%
  4. Pain: 4 people, 30.77%
  5. Itching: 4 people, 30.77%
  6. Burning Sensation: 4 people, 30.77%
  7. Constipation: 4 people, 30.77%
  8. Hypersensitivity: 4 people, 30.77%
  9. High Blood Pressure: 4 people, 30.77%
  10. Diabetes: 4 people, 30.77%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and Colcrys?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan succinate and Colcrys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Colcrys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colcrys and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and colchicine (the active ingredients of Sumatriptan succinate and Colcrys, respectively), and Sumatriptan succinate and Colcrys (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: